businesspress24.com - Cromos Pharma Begins Operations in Belarus
 

Cromos Pharma Begins Operations in Belarus

ID: 1239640

(firmenpresse) - MOSCOW -- (Marketwired) -- 06/24/13 -- Cromos Pharma, a full service regional contract research organization (CRO), announced today that it has begun operations in the Republic of Belarus. These operations are being conducted through Cromos Pharma's office in the city of Smolensk, Russia.

"When it comes to clinical research, Belarus has many attractive attributes," noted Dr. Vladimir Bogin, Chief Executive Officer of Cromos Pharma. "Belarus has a developed healthcare system, well-trained medical professionals with good knowledge of ICH/GCP and standards of care that are comparable to European medical practice," continued Dr. Bogin.

"Recent legislative concessions allow for a significant increase in the reimbursement of study teams. This signifies a substantial shift in state policy towards clinical research and has sparked a renewed interest in clinical trials by both medical centers and investigators," said Cromos Pharma's Managing Director, Andrey Tarakanov, MD. "The staff of our Smolensk office has considerable experience in all stages of clinical trial conduct in Belarus, and Cromos Pharma has a strong working relationship with local medical centers and investigators," he continued.

"Recent addition of Georgia and now of Belarus to its geographic footprint will allow Cromos Pharma to compete for even larger multi-center, international clinical trials," concluded Dr. Bogin.

Cromos Pharma has recently published a white paper () which provides comprehensive updates on the Belarusian regulatory changes along with a brief overview of its healthcare system.

About Cromos Pharma, LLC:
Cromos Pharma, LLC is a regional contract research organization (CRO) with operations in Russia, Ukraine, Georgia, Belarus and Baltic States, and a business development office in the United States. The company provides a full spectrum of trial-related services which include regulatory approvals, medical writing, feasibility assessments, monitoring, project management and warehousing. Cromos Pharma, LLC is a privately owned company.









Contact information for Russia, Ukraine, Georgia and countries of C&E Europe:
Vladimir Krechikov, MD, PhD
Director of Business Development
Tel: +7 495 748 02 37
Toll free (for calls within Russia only): 8 800 100 21 78
Fax: +7 495 748 02 38
Email:


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Platine Pharma and Indicia Biotechnology Join Forces to Strengthen Leadership in Immuno-Assays
Prima BioMed to Move Forward With Phase 2 Clinical Program for CVac(TM) in Pancreatic, Colorectal, and Triple-Negative Breast Cancers
Bereitgestellt von Benutzer: Marketwired
Datum: 24.06.2013 - 10:48 Uhr
Sprache: Deutsch
News-ID 1239640
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

MOSCOW


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 126 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Cromos Pharma Begins Operations in Belarus
"
steht unter der journalistisch-redaktionellen Verantwortung von

Cromos Pharma (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Cromos Pharma



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 1
Guests online: 76


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.